STAT

With a closer look at immune systems, scientists hope to steer infants back onto a healthy track

What if you could give vulnerable infants an immunological tweak to steer them back onto a healthy track?

What if you could lower the risk that newborns would develop life-threatening infections? Optimize — even personalize — the timing of vaccines given early in life? Figure out which babies aren’t developing competent immune systems or are at risk of type 1 diabetes? What if you could give them an immunological tweak to steer them back onto a healthy track?

New research suggests those “what ifs?” may someday be reality.

A , from researchers at Boston Children’s Hospital and colleagues in several other countries, used minute amounts of blood drawn in the first week of life to

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT1 min read
STAT+: Nuclear Regulatory Commission Advisers Beset By Conflicts Of Interest, Report Finds
Advisers to the Nuclear Regulatory Commission, a U.S. government agency tasked with ensuring the safe use of radioactive materials, were beset by conflicts of interest, report finds

Related Books & Audiobooks